KG-2019

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameKG-2019

Drug Alias NameKG-2019

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJN Nova Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A